French shares fall again despite steady Wall Street
Despite a steady early session on Wall Street, French shares began the week with another weak performance on Monday, with banking shares leading the decline.
The Paris Bourse's CAC blue-chip index ended the day off by 3.96 per cent, at 3,067.35, with declining issues outnumbering winners by about 12 to 1.
The bank Societe Generale was the biggest loser of the session, falling by 15.56 per cent, to 38.00 euros, while another French bank, Credit Agricole, slipped by 11.17 per cent, to 10.10 euros, and French-Belgian financial services group Dexia lost 10.09 per cent, to 3.92 euros.
Troubled car maker Renault, which last week announced drastic production cuts due to low demand, lost 12.61 per cent per cent, to 19.40 euros.
The CAC 40 has lost more than 45 per cent of its value since the beginning of the year, and is off by more than 26 per cent over the past month alone.
- Login or register to post comments
Print
Email to friend
Related Articles
- Weak Wall Street pulls down French shares
- Wall Street again pulls down French shares
- French shares rebound due to central banks, Wall Street
- French shares fall sharply in roller-coaster session
- French shares gain but banking, environment stocks falter
- French shares rise on Wall Street showing, capital injections
- French shares limit damage after New York stock debacle
- Paris Bourse resisting Wall Street's downward pull
There has been an up side to the abysmal state of American economy, as more multi-generation families are choosing to live together, driven partly...
Apparently, the healthcare debate has forced into the Twilight Zone, with President Obama saying passing the bill means 3,000% decrease for...
University of Michigan researchers have found a chemical in bananas they believe can prove helpful in protecting women from HIV infection.
...
Prosecutors say a former Fall River dentist who has had his license to practice suspended in three states repeatedly billed for work using the...
In a special edition of the Journal of the American Medical Association, commentators say the US health system is under strain from the rising...
In its letter released Tuesday, the US Food and Drug Administration (FDA) informs Glenmark Pharmaceuticals Ltd. to have sold nitroglycerin tablets...
In an exciting win for gene testing and personalized medicine, doctors say it is possible to get a tricky dose right and keep patients out of...
According to US researchers, while younger people with colon cancer are more likely to receive chemotherapy after surgery than older patients, it...
Adopting a controversial plan the Department of Health and Mental Hygiene proposed 14 months ago, the New York City Board of Health will rate...
Law enforcement officials and marijuana advocates for Washington State have been called upon to change how pot is regulated and how those who grow...
Kathleen Sebelius, Secretary of Health and Human Services said Tuesday immediate benefits will be visible to consumers via increased insurer...
As the lawmakers clashed fiercely Tuesday, political manoeuvring in the Capitol saw Democrats struggling to defend procedural shortcuts in order...
